Find More Contacts for Vizgen
Terry Lo
CEO, President
Executive Management
2 emails found 2 phone numbers found
View contacts for Vizgen to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email

Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and detection efficiency at subcellular resolution. The high

throughput and resolution and the low cost per cell achieved by the technology will enable a wide range of tissue-scale basic research and development and will be instrumental to efforts to discover and map cell types and states in a range of tissues and organisms.

Lists Featuring This Company

Private United States Companies (Top 10K)
9,853 Number of Organizations ? $976.3B Total Funding Amount ? 91,022 Number of Investors
United States Companies (Top 10K)
9,965 Number of Organizations ? $2.1T Total Funding Amount ? 94,046 Number of Investors
Greater Boston Area Biotechnology Companies
1,560 Number of Organizations ? $111.8B Total Funding Amount ? 5,575 Number of Investors
Greater Boston Area Late Stage Companies
184 Number of Organizations ? $35.3B Total Funding Amount ? 1,988 Number of Investors

Frequently Asked Questions

Where is Vizgen's headquarters? Vizgen is located in Cambridge, Massachusetts, United States.Who invested in Vizgen? Vizgen has 9 investors including David Walt and Blue Water Life Science Advisors.How much funding has Vizgen raised to date? Vizgen has raised $136.2M.When was the last funding round for Vizgen? Vizgen closed its last funding round on Jun 3, 2022 from a Series C round.